Literature DB >> 6352656

Ceftazidime in the treatment of complicated respiratory and urinary tract infections.

L H Loebis, K J Williams.   

Abstract

The efficacy of ceftazidime was examined in 46 patients, 33 with respiratory and 13 with urinary tract infections. Ceftazidime was given following the failure of conventional therapy or when bacteria had been isolated within a week of treatment. It was also used in infections arising as a complication of an indwelling catheter or in emergency situations when alternative antibiotics were inappropriate. Ceftazidime was found to be very successful in the treatment of these infections and only two patients failed to respond clinically, one of these being a patient with an indwelling catheter and one treated as an emergency who had severe underlying pathology. One patient was considered unevaluable because he died of his underlying condition during treatment. Serum levels of ceftazidime are described following im and iv administration of 0.5 and 1 g doses.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352656     DOI: 10.1093/jac/12.suppl_a.59

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

1.  A multicentre, randomized comparative study of 500 mg versus 1,000 mg ceftazidime t.d.s. for treatment on gram-negative infections.

Authors:  H Mattie; M W Kunst; H I Schievink; P L Jonker; P de Jonge
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

Review 2.  Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.